BMS 665053 Chemische Eigenschaften,Einsatz,Produktion Methoden

Biochem/physiol Actions

BMS-665053 is a pyrazinone-containing antagonist that targets corticotropin-releasing factor/hormone (CRF or CRH) receptor 1 (CRF1, CRF-R1, CRFR-1, CRH-R1, CRHR-1) with high affinity (IC50 10 μM against 150 pM ovine CRF in binding assay). BMS-665053 exhibits anxiolytic efficacy in a defensive withdrawal anxiety test in rats in vivo (10 mg/kg p.o.) with good oral bioavailability (F = 52%).

BMS 665053 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

BMS 665053 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32467	58
TargetMol Chemicals Inc.	+17819995354	marketing@targetmol.com	United States	19956	58
Sigma-Aldrich	021-61415566 800-8193336	orderCN@merckgroup.com	China	51395	80
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44909	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	29867	58
Merck KGaA	--	ordercn@merckgroup.com	China	6394	58
Biosynth Biological Technology (Suzhou) Co Ltd	--	sales@biosynth.com	China	6051	58

---

• BMS 665053
• 5-chloro-1-[(1S)-1-cyclopropylethyl]-3-[2,6-dichloro-4-(difluoromethoxy)anilino]pyrazin-2-one
• 2(1H)-Pyrazinone, 5-chloro-1-[(1S)-1-cyclopropylethyl]-3-[[2,6-dichloro-4-(difluoromethoxy)phenyl]amino]-
• BMS-665053 >=98% (HPLC)
• 1173435-64-7
• C16H14Cl3F2N3O2